From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms
about
The Role of Reactive Oxygen Species in Myelofibrosis and Related NeoplasmsA model for the epigenetic switch linking inflammation to cell transformation: deterministic and stochastic approachesInsight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-reviewDynamic imbalance between cancer cell subpopulations induced by transforming growth factor beta (TGF-β) is associated with a DNA methylome switch.Predicting the impact of non-coding variants on DNA methylation.SAMD9L inactivation promotes cell proliferation via facilitating G1-S transition in hepatitis B virus-associated hepatocellular carcinoma.Effect of estrogen receptor α binding on functional DNA methylation in breast cancer.Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis.Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients.The Liver MicroRNA Expression Profiles Associated With Chronic Hepatitis C Virus (HCV) Genotype-4 Infection: A Preliminary Study.Tumorigenic potential is restored during differentiation in fusion-reprogrammed cancer cells.Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.Hepatitis viruses exploitation of host DNA methyltransferases functions.Surgery for Benign Gynecological Disorders Improve Endometrium Receptivity.The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis.Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
P2860
Q26779929-FA52C445-12D5-4D14-B66C-538BCF4C6B4AQ31151086-908D2774-1248-44AA-B9F8-E2DC1E93C4E8Q33731768-12C5D0F6-B6E9-4FFB-BEB4-48CDBE3889B6Q33806379-A2ECB524-3F91-4C68-A54C-9656D23F59FFQ33878882-5DB56ECB-5166-46A9-AC83-1A387FD8709BQ33970149-0972EF95-46FC-4D8A-9523-6168B04DDB42Q34000392-CC070296-0ABD-44F0-BA94-F9C65DC08D45Q35793705-56AD2B5C-2A55-488C-974D-60B42E1E1A0AQ36961950-509F3258-6F07-4131-9860-1AA94C6F0C3BQ36969738-F1E570F7-1E3F-48AE-ACD1-2AAD985A3F7FQ37151483-A7DE86B2-568B-422D-B89F-12FA78F299C5Q37151661-D3055AD3-F62D-45A7-97E4-2DCE27AEB121Q38543225-F096FAB7-2D37-4322-ADF5-952F242CA27DQ38916691-09708319-B506-44F8-AF0A-FE1D848DCD9DQ40273466-7486BBF8-3D22-4D3B-83F8-0357273BB47DQ46544918-452D8DA2-4614-4CEC-B190-B59044CE64C8Q52997142-A762AF2C-FC61-4E26-B891-7627C7C28BD0
P2860
From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
From hepatitis to hepatocellul ...... tion and epigenetic mechanisms
@ast
From hepatitis to hepatocellul ...... tion and epigenetic mechanisms
@en
From hepatitis to hepatocellul ...... tion and epigenetic mechanisms
@nl
type
label
From hepatitis to hepatocellul ...... tion and epigenetic mechanisms
@ast
From hepatitis to hepatocellul ...... tion and epigenetic mechanisms
@en
From hepatitis to hepatocellul ...... tion and epigenetic mechanisms
@nl
prefLabel
From hepatitis to hepatocellul ...... tion and epigenetic mechanisms
@ast
From hepatitis to hepatocellul ...... tion and epigenetic mechanisms
@en
From hepatitis to hepatocellul ...... tion and epigenetic mechanisms
@nl
P2860
P3181
P356
P1433
P1476
From hepatitis to hepatocellul ...... tion and epigenetic mechanisms
@en
P2093
Marion Martin
Zdenko Herceg
P2860
P2888
P3181
P356
10.1186/GM307
P407
P577
2012-01-31T00:00:00Z
P5875
P6179
1023386546